Rankings
▼
Calendar
HROW
Harrow Health, Inc.
$1B
Q4 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$89M
+33.3% YoY
Gross Profit
$71M
79.3% margin
Operating Income
$16M
17.5% margin
Net Income
$7M
7.4% margin
EPS (Diluted)
$0.18
QoQ Revenue Growth
+24.4%
Cash Flow
Operating Cash Flow
$39M
Free Cash Flow
$38M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$399M
Total Liabilities
$347M
Stockholders' Equity
$52M
Cash & Equivalents
$73M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$89M
$67M
+33.3%
Gross Profit
$71M
$53M
+34.0%
Operating Income
$16M
$13M
+20.9%
Net Income
$7M
$7M
-2.2%
← FY 2025
All Quarters
HROW Q4 2025 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena